Jaakko Rautakorpi
Publications
- Switching to Subcutaneous Infliximab Maintenance Therapy Is Effective in Patients with Inflammatory Bowel Disease (2025)
- Digestive Diseases and Sciences
(A1 Refereed original research article in a scientific journal) - Real-life experiences of switching from intravenous to subcutaneous vedolizumab maintenance therapy in patients with inflammatory bowel disease (2024)
- European Journal of Gastroenterology and Hepatology
(A1 Refereed original research article in a scientific journal)